Most of the currently available antiepileptic drugs have a low therapeutic ratio and therefore a drug interaction causing elevation of the serum level of one of these compounds can readily lead to drug intoxication. Phenytoin, in particular, is vulnerable because its metabolism is dose-related and at therapeutic serum levels the enzyme system involved in its degradation is easily inhibited by concurrent drug administration.
As multiple drug therapy has traditionally been practised in the management of epilepsy, clinically important interactions are common. Furthermore, most of the drugs used in the treatment of major epilepsies are potent inducers of hepatic microsomal enzymes and can therefore stimulate the metabolism of concurrently-administered drugs to such an extent that they may be rendered ineffective. The use of one drug alone is recommended, where possible, in the management of epilepsy.
KeywordsPhenobarbitone Epileptic Patient Griseofulvin Sodium Valproate Primidone
Unable to display preview. Download preview PDF.
- Eadie, M.J. and Tyrer, J.H.: Anticonvulsant Therapy. Pharmacological Basis and Practice, p.64 (Churchill Livingstone, Edinburgh 1974).Google Scholar
- Edwards, V.E. and Eadie, M.J.: Clonazepam —clinical study of its effectiveness as an anticonvulsant. Proceedings of the Australian Association of Neurology 10: 61–66 (1973).Google Scholar
- Hansen, J.M.; Siersbaek-Nielsen, K.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta Neurologica Scan-dinavica 189: 15–19 (1971).Google Scholar
- Houghton, G.W. and Richens, A.: The effect of benzodiazepines and pheneturide on phenytoin metabolism in man. British Journal of Clinical Pharmacology 1: 344–345 (1974c).Google Scholar
- Johannessen, S.I. and Strandjord, R.E.: The influence of phenobarbitone and phenytoin on carbamazepine serum levels; in Schneider et al. (Eds) Clinical Pharmacology of Antiepileptic Drugs (Springer-Verlag, Heidelberg 1976).Google Scholar
- Kutt, H.: Diphenylhydantoin. Interactions with other drugs in man; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p. 168 (Raven Press, New York 1972).Google Scholar
- Kutt, H.: Interactions of antiepileptic drugs. Epilepsia (New York) 16: 393–402 (1975).Google Scholar
- Lancet Annotation: Paracetamol hepatotoxicity. Lancet 2: 1189 (1975).Google Scholar
- Latham, A.N.: Some observations on the value of serum drug concentrations and urinary D-glucaric acid determinations in assessing the effects of some anticonvulsant drugs on hepatic enzyme activity. Ph.D. Thesis, University of London (1974).Google Scholar
- Latham, A.N. and Richens, A.: Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone? British Journal of Clinical Pharmacology 47: 615P (1973).Google Scholar
- Padgham, C. and Richens, A.: Quinine metabolism: a useful index of hepatic drug metabolising capacity in man? British Journal of Clinical Pharmacology 1: 352–353 (1974).Google Scholar
- Richens, A.: Drug Treatment of Epilepsy (Henry Kimpton, London 1976).Google Scholar
- Richens, A. and Houghton, G.W.: Effect of drug therapy on the metabolism of phenytoin; in Schneider et al. (Eds) Clinical Pharmacology of Anti-Epileptic Drugs (Springer-Verlag, Heidelberg 1975).Google Scholar
- Richens, A. and Houghton, G.W.: Drug combinations and interactions in severe epilepsy. Proceedings of 6th International Symposium on Epilepsy. Brussels, September 15–18 (1976).Google Scholar
- Richens, A.; Scoular, I.T.; Ahmad, S. and Jordan, B.J.: Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy (MCS Consultants, England 1976).Google Scholar
- Richens, A. and Woodford, F.P.: Anticonvulsant Drugs and Enzyme Induction (Associated Scientific Publishers, Amsterdam 1976).Google Scholar
- Vakil, S.D.; Critchley, E.M.R.; Philips, J.C.; Fahim, Y.; Haydock, C.; Cocks, A. and Dyer, T.: The effect of sodium valproate (Epilim) on phenytoin and phenobarbitone blood levels; Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the treatment of Epilepsy (MCS Consultants, England 1976).Google Scholar
- Viala, A.; Cano, J.P.; Dravet, L.; Tassinari, C.A.; Roger, J. and Angeletti-Philippe, A.: Blood levels of diazepam (Valium) and N-desmethyl diazepam in the epileptic child. Psychiatry, Neurology and Neurosurgery 74: 153–158 (1971).Google Scholar